Advances in machine learning show considerable promise to understand patient data and predict future events and outcomes in the treatment of disease. Such results provide early warning scores to avoid complications and adverse events, such as sepsis, readmissions and death, through to personalised treatments and dosage specifically optimised to each patient.

Datarwe aims to develop the world’s most comprehensive acute care medical research data platform, enabling medical researchers to develop next-generation Artificial Intelligence (AI) clinical diagnostic tools and technologies. The platform collects data from de-identified Intensive Care episodes, recording all demographics, lab results, drug administration, and high-frequency vital sign monitoring during a patient’s stay in ICU. Additionally, data are enriched to be research ready, and analytics and tools provided to the data scientists to accelerate their medical research.